摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(R)-5-hydroxy-2,3,4,5-tetrahydro-1H-1-benzazepine | 294196-51-3

中文名称
——
中文别名
——
英文名称
(R)-5-hydroxy-2,3,4,5-tetrahydro-1H-1-benzazepine
英文别名
R-2,3,4,5-tetrahydro-1H-benzo[b]azepin-5-ol;(5R)-2,3,4,5-tetrahydro-1H-1-benzazepin-5-ol
(R)-5-hydroxy-2,3,4,5-tetrahydro-1H-1-benzazepine化学式
CAS
294196-51-3
化学式
C10H13NO
mdl
——
分子量
163.219
InChiKey
DNCKQRQKWJCPMQ-SNVBAGLBSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    310.8±21.0 °C(Predicted)
  • 密度:
    1?+-.0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.5
  • 重原子数:
    12
  • 可旋转键数:
    0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.4
  • 拓扑面积:
    32.3
  • 氢给体数:
    2
  • 氢受体数:
    2

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    4-[(2-甲基苯甲酰基)氨基]苯甲酰氯(R)-5-hydroxy-2,3,4,5-tetrahydro-1H-1-benzazepine吡啶 作用下, 以 二氯甲烷N,N-二甲基甲酰胺 为溶剂, 反应 1.5h, 生成 (+)-(5R)-5-hydroxy-N-[4-[(2-methylbenzoyl)amino]benzoyl]-2,3,4,5-tetrahydro-1-benzazepine
    参考文献:
    名称:
    Enantioselective Synthesis of the Metabolites of Vasopressin V2 Receptor Antagonist OPC-31260 via Lipase-Catalyzed Transesterification
    摘要:
    The optical isomers of 5-dimethylamino-1-[4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-1-benzazepine (OPC-31260, 1) and its metabolites (2, 3, 4, 5 and 6) were enantioselectively synthesized. The chiral acetate 8b and alcohol 7a were prepared via the resolution of the racemic alcohol (+/-)-7 using the lipase-mediated transesterification in vinyl acetate. The compounds 8b and 7a were converted to the hydroxy metabolites (2a and 2b), the methylamine metabolites (3a and 3b), the dimethylamines (1a and 1b), and the amine metabolites (4a and 4b) in several steps while maintaining their absolute configurations. The 4,5-diol metabolites (5a, 5b, 6a and 6b) were synthesized from the key intermediates obtained by the lipase-catalyzed transesterification. (C) 2000 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0040-4020(00)00388-4
  • 作为产物:
    描述:
    (R)-5-hydroxy-1-(p-toluenesulfonyl)-2,3,4,5-tetrahydro-1H-1-benzazepinemagnesium 作用下, 以 甲醇 为溶剂, 反应 5.0h, 以59%的产率得到(R)-5-hydroxy-2,3,4,5-tetrahydro-1H-1-benzazepine
    参考文献:
    名称:
    Enantioselective Synthesis of the Metabolites of Vasopressin V2 Receptor Antagonist OPC-31260 via Lipase-Catalyzed Transesterification
    摘要:
    The optical isomers of 5-dimethylamino-1-[4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-1-benzazepine (OPC-31260, 1) and its metabolites (2, 3, 4, 5 and 6) were enantioselectively synthesized. The chiral acetate 8b and alcohol 7a were prepared via the resolution of the racemic alcohol (+/-)-7 using the lipase-mediated transesterification in vinyl acetate. The compounds 8b and 7a were converted to the hydroxy metabolites (2a and 2b), the methylamine metabolites (3a and 3b), the dimethylamines (1a and 1b), and the amine metabolites (4a and 4b) in several steps while maintaining their absolute configurations. The 4,5-diol metabolites (5a, 5b, 6a and 6b) were synthesized from the key intermediates obtained by the lipase-catalyzed transesterification. (C) 2000 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0040-4020(00)00388-4
点击查看最新优质反应信息

文献信息

  • Regio- and stereoselective benzylic hydroxylation to synthesize chiral tetrahydroquinolin-4-ol and tetrahydro-1H-benzo[b]azepin-5-ol with Pseudomonas plecoglossicidas
    作者:Daijun Zheng、Min Yang、Junrui Zhuo、Ke Li、Hongyan Zhang、Jiawei Yang、Baodong Cui、Yongzheng Chen
    DOI:10.1016/j.molcatb.2014.09.013
    日期:2014.12
    Two whole-cell biocatalysts were found to have C-H oxidation activity with high R-enantioselectivity on 1,2,3,4-tetrahydroquinoline (THQ) and 2,3,4,5-tetrahydro-1H-benzo[b]azepine (TBA). R-1,2,3,4-tetrahydroquinolin-4-ol ((R)-THQL) and R-2,3,4,5-tetrahydro-1H-benzo[b]azepin-5-ol ((R)-TBAL) were smoothly obtained with 82% yield in 99% e.e. and 99% yield in 98% e.e., respectively. (C) 2014 Elsevier B.V. All rights reserved.
查看更多